Utility of Oral Quinine Sulfate for the Treatment of Brugada Syndrome Presenting as Electrical Storm in Remote Areas: Resilience in the COVID-19 Era

Abstract

Electrical storm is a malignant presentation of Brugada syndrome (BrS). Pharmacologic antiarrhythmic therapy is mandatory for this condition, followed by implantation of an implantable cardioverter-defibrillator to prevent sudden cardiac death. We report a case of a BrS patient presenting with electrical storm in a remote area. A referral to tertiary healthcare services was turned down due to the capacity demands of COVID-19 cases. Oral quinine was used as a bailout therapy and successfully maintained the arrhythmia suppression. Our case confirms that quinine is a reliable option to suppress electrical storm in BrS.

Access to Document

Other files and links

• Link to publication in Scopus
• Open Access Version Available

Fingerprint